We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Laparoendoscopic Single-site Radical Nephrectomy for Localized Renal Cell Carcinoma (LESS)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified July 2009 by Seoul National University Hospital.
Recruitment status was:  Active, not recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00945984
First Posted: July 24, 2009
Last Update Posted: July 28, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Seoul National University Hospital
  Purpose
Surgical resection is the only potential curative treatment available for renal cell carcinoma. The purpose of this study is to clarify the surgical and oncologic outcomes of laparoendoscopic single-site radical nephrectomy for localized Renal Cell Carcinoma.

Condition Intervention
Localized Renal Cell Carcinoma Procedure: Radical nephrectomy

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Retrospective
Official Title: Comparison of Laparoendoscopic Single-site Radical Nephrectomy With Conventional Laparoscopic Radical Nephrectomy for Localized Renal Cell Carcinoma

Resource links provided by NLM:


Further study details as provided by Seoul National University Hospital:

Primary Outcome Measures:
  • Surgical outcomes such as operative time, estimated blood loss [ Time Frame: 1 year ]

Enrollment: 36
Study Start Date: March 2009
Groups/Cohorts Assigned Interventions
LESS
Patients who underwent LESS radical nephrectomy
Procedure: Radical nephrectomy
Surgical options to treat localized renal cell carcinoma
Conventional laparoscopy
Patients who underwent conventional laparoscopic radical nephrectomy
Procedure: Radical nephrectomy
Surgical options to treat localized renal cell carcinoma

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Tertiary care center
Criteria

Inclusion Criteria:

  • Patients with localized renal cell carcinoma

Exclusion Criteria:

  • Patients with lymph node or distant metastasis
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00945984


Locations
Korea, Republic of
Seoul National University Hospital
Seoul, Korea, Republic of, 110-744
Sponsors and Collaborators
Seoul National University Hospital
Investigators
Study Chair: Hyeon Hoe Kim, PhD Seoul National University Hospital
  More Information

Responsible Party: Hyeon Hoe Kim, Seoul National University Hospital
ClinicalTrials.gov Identifier: NCT00945984     History of Changes
Other Study ID Numbers: LESSRNx
First Submitted: July 22, 2009
First Posted: July 24, 2009
Last Update Posted: July 28, 2009
Last Verified: July 2009

Keywords provided by Seoul National University Hospital:
Localized renal cell carcinoma

Additional relevant MeSH terms:
Carcinoma
Carcinoma, Renal Cell
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms
Adenocarcinoma
Kidney Neoplasms
Urologic Neoplasms
Urogenital Neoplasms
Neoplasms by Site
Kidney Diseases
Urologic Diseases